Partnerships in Shared Decision Making

This webinar was recorded in March 2018.

Webinar Objectives

• Review the prevalence/economic impact of allergic rhinitis (AR), also known as nasal allergies or hay fever
• Define what is meant by difficult-to-manage Allergic Rhinitis
• Recognize that optimal AR control is currently not being achieved in many patients
• Discuss the impact of difficult-to-manage AR on quality of life and comorbidities
• Discuss the need for shared decision making for immunotherapy options

Speaker

Dr. Don Buckstein